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Abstract
Background: Treatment for horses with pythiosis of a limb is challenging. This study aims to evaluate the effects of
administering amphotericin B in a 10 % solution of dimethylsulfoxide by intravenous regional limb perfusion (IRLP)
to treat horses for cutaneous pythiosis of a limb.
Results: All 15 of the horses treated had complete resolutions of their lesion between 6 to 9 weeks after a single
IRLP treatment. No complications were observed at the site of venipuncture for IRLP. Before initiation of treatment,
there was anemia and marked leucocytosis which resolved following treatment. Serum biochemistry showed no
significant changes.
Conclusions: IRLP administration of amphotericin B in a 10 % DMSO solution was easily performed, relatively
inexpensive and an effective treatment for treating horses for pythiosis of a limb and resolved the infection with no
complications.
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Background
Treatment of horses for infection of a limb with Pythium
insidiosum is challenging, and its effectiveness appears to
depend on such factors as size and site of the lesion, dur-
ation of infection, immunocompetence, and the type of
treatment. Systemically administered antifungal drugs,
such as potassium or sodium iodide, ketoconazole, micon-
azole, fluconazole, itraconazole, and amphotericin B, have
been administered with or without the surgical excision of
the lesion to improve outcomes [1–3]. However, these
drugs are considered hazardous and are expensive when
administered systemically to horses, and because Pythium
insidiosum is not a true fungus, this protistal organism has
increased resistance to most available antifungal agents [3,
4]. Dória et al. [5] reported that intravenous regional limb
perfusion (IRLP) with amphotericin B is effective for treat-
ing horses with a cutaneous lesion of pythiosis of a limb,
resolving the infection with manageable complications,
such as oedema of the limb, signs of pain during palpation
of the limb, and inflammation at the site of venipuncture
for IRLP. Their study demonstrated that 92 % of the
horses (n = 11) affected by Pythium insidiosum and pre-
senting with exuberant granulation tissue in the distal
aspect of a thoracic or pelvic limb that were treated with
intravenous regional perfusion with amphotericin B had
complete resolution of their lesions 35 days after one
treatment or 60 days after two treatments. Dória et al.
[5] considered the intravenous regional perfusion of
amphotericin B to be an effective adjunct therapy to
surgical excision and thermocauterization in treating
horses for pythiosis of the distal portion of the limb.
We hypothesized that better results with fewer compli-
cations might be achieved if dimethylsulfoxide (DMSO)
is added to the perfusate when amphotericin B is admin-
istered by IRLP as a treatment for pythiosis of a limb.
We reasoned that adding DMSO to the perfusate would
achieve a higher concentration of amphotericin B within
the infected tissues, and because DMSO has been shown
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to be an effective anti-inflammatory agent, its addition
to the perfusate would reduce inflammation at the site
of intravenous administration. It may also possess some
inhibitory effects on the growth of a variety of fungi as a
result of its effect on the immune response and as a re-
sult of reducing endotoxin-induced tissue damage.
Studies have shown that intravenous administration of
DMSO results in vascular dilation and increased flow of
blood through experimentally created cutaneous flaps
[6–9]. Such properties associated with its ability to pene-
trate biological membranes provide a rationale for its
use in conjunction with an antifungal drug for regional
limb perfusion [10].
Thus, we evaluated the effects of administering
amphotericin B in a 10 % solution of DMSO by IRLP as
an adjunct therapy to surgical excision, hoping to dimin-
ish the detrimental vascular effects associated with ad-
ministration of amphotericin B, to treat horses for
pythiosis of a limb.
Methods
This study was approved by the University of Cuiabá
Animal Care and Ethics Committee, under protocol num-
ber 2009–228. Fifteen horses (8 males and 7 females, age
4 months to 15 years, weighing 100–420 kg) diagnosed
with pythiosis were studied. This research was carried out
on horse farms located in Tocantins state (n = 1), São
Paulo state (n = 2) and Mato Grosso state (n = 12), Brazil.
The presumptive diagnoses were made on the basis of his-
torical data, the gross appearance of the granulomatous le-
sion, and the histological appearance of the lesion. Lesions
were located distal to the cubital joint (elbow) or the
femorotibial joint (stifle). In preparation for the treatment,
feed was withheld for 12 h before treatment was adminis-
tered. A catheter was placed into a jugular vein, and the
horses were tranquillized with acepromazine (0.1 mg/kg)
and then anesthetized with guaiacol glycerol ether (100
mg/kg), ketamine (2 mg/kg), and midazolam (0.1 mg/kg).
Horses were positioned in lateral recumbency with the
lesion uppermost. The site of the lesion was prepared for
surgery by scrubbing the site with soap and applying di-
lute povidone-iodine solution and 70 % isopropyl alcohol.
An Esmarch tourniquet was applied proximal to the lesion
to prevent hemorrhaging, making it possible to surgically
remove the exuberant granulation tissue and kunkers
safely avoiding exposing the bone or entering a synovial
structure. Tissues (1 cm3) were collected and fixed in
10 % formalin for histological (hematoxylin and eosin;
Grocott’s methenamine silver) and immunohistochemical
(the labeled streptavidin biotin method) analyses, per-
formed as previously reported [11–13]. After surgery, the
Esmarch tourniquet was partially released to identify
bleeding vessels for cauterization with electric thermocau-
tery, and the site of the lesion was bandaged. The Esmarch
tourniquet was repositioned and retightened, and a super-
ficial vein (the cephalic, palmar digital, saphenous, plantar
digital, or dorsal digital vein) next to the lesion and distal
to the tourniquet was catheterized using a 20-, 22-, or
24-ga catheter for administration of the drugs. The
catheterized vein was injected with 60 mL of a solution
containing 50 mg (10 mL) of amphotericin B1, 6 mL of
medical grade DMSO2 and 44 mL of lactated Ringer’s
solution. The injection was delivered using finger pres-
sure over 5 min using a 60-mL syringe connected to an
extension line. The catheter was removed after the ad-
ministration, and firm pressure was applied manually to
the site of venipuncture. The tourniquet was released 45
min after the administration of the solution of ampho-
tericin B and DMSO.
Lesions were evaluated before treatment (Day 0) and
then weekly (1 to 9 weeks) after the administration of
the solution of amphotericin B and DMSO until the le-
sions were completely healed. At the same time points,
blood samples were collected for haematological and
biochemical analyses using standard techniques [14].
The lesion’s size (length and width) was determined at
day 0 using a ruler. The lesions were assessed qualita-
tively, and the response to therapy was determined by
clinical observation (i.e., gross appearance of the lesion).
The appearance of the lesion was compared to the
photographic appearance of the lesion at the times of
previous evaluations. A wound was considered completely
healed when it was completely covered with epithelium.
The affected limb was evaluated for regional swelling, sen-
sitivity to palpation, and signs of inflammation at the site
of venipuncture.
The data were analyzed with the Statistical Analysis
System (SAS.2011). Normality of the data distribution
was evaluated by the Shapiro-Wilk test. A one-way ana-
lysis of variance with repeated measures, followed by a
Tukey test, was used for the comparisons of the weekly
data. The differences were considered to be statistically
significant when P ≤ 0.05.
Results
The pythiosis lesions were located in different regions,
including the radius (20 %), carpus (6.66 %), metacarpus
(6.66 %), tibia (6.66 %), tarsus (6.66 %), metatarsus
(6.66 %), fetlock and pastern (46.7 %). At day 0, all of
the horses had large lesions ranging from 12 to 50 cm in
length (mean length 27 cm) and 15 to 40 cm in width
(mean width 25 cm) and surrounded 90° (4 horses), 180°
(7 horses) or 360° (4 horses) of the affected areas. The
lapse of time between emergence of the lesion and the
beginning of treatment with amphotericin B and DMSO
ranged from two to five months (average, three months).
Before treatment (D0), the affected limb was swollen,
and the lesion was filled with exuberant, ulcerated
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granulation tissue and surrounded by oedematous tis-
sue. The surface of the granulation tissue was nodular
and covered with a mucosanguineous viscous exudate.
The tissue sections had sinuses containing kunkers,
usually surrounded by seropurulent discharge. The
horses showed signs of intense pruritus that was char-
acterized by self-mutilation.
The histopathological diagnosis was pyogranulomatous
dermatitis associated with the pseudo hyphae character-
istic of Pythium insidiosum (subcutaneous pythiosis),
confirmed by the immunohistochemistry analysis. Surgi-
cal excision of the exuberant granulation tissue and IRLP
administration of amphotericin B and DMSO resulted
in complete resolution of the lesions. All 15 lesions
regressed after a single administration of a solution con-
taining amphotericin B and DMSO. By one week after a
single treatment, exudate, sinuses, and kunkers had dis-
appeared from the lesions, and the granulation tissue
had regressed and turned from white to pink-yellow. In
subsequent weeks, the granulation tissue became pink
and flat, and a margin of epithelialization could be seen
moving centripetally. Epithelialization was complete by 6
weeks in 5 horses, 4 of which had lesions surrounding
90° of the affected area and 1 of which surrounded 180°
of the affected area; 8 weeks in 5 horses of which had le-
sions encompassing 180° of the limb; and 9 weeks in 5
horses, 1 of which had lesions encompassing 180° of the
limb and 4 of which encompassed 360° of the limb
(Fig. 1). No complications at the site of venipuncture for
RLP were observed in any of the horses, and no horse
had recurrence of pythiosis at the time of follow-up, one
year after resolution of disease.
Haematology showed that there was an increase in the
RBC and PCV after treatment. Anemia resolved by 2
weeks after IRLP. The total and differential leucocyte
counts were significantly increased before treatment,
with neutrophilia and eosinophilia. The neutrophil count
and the eosinophil count decreased and returned to nor-
mal values by 2 weeks after treatment. Increased serum
concentration of fibrinogen found when the horses were
admitted had decreased to normal values by 2 weeks
after treatment. No significant abnormalities were noted
during examination of the results of other biochemical
assays (Table 1).
Discussion
We report the successful treatment of horses for cutane-
ous pythiosis of the limb after IRLP using amphotericin
B and DMSO in combination with excision of the ex-
uberant granulation tissue. Our results indicate that the
treatment we administered is successful, cost-effective,
and easily performed.
The challenge of treating pythiosis is characterized by
the severity of the disease and by the absence of gold
standard chemotherapy. Complete surgical excision is
the treatment of choice, but the disease is often too ex-
tensive at the time of diagnosis to allow complete resec-
tion. Immunotherapy and/or the systemic, intralesional,
and topical administration of antifungal drugs has been
combined with surgical excision to improve therapeutic
efficacy [3, 15]. Amphotericin B, when administered sys-
temically, does not reach a therapeutically effective con-
centration at the site of infection with Pythium
insidiosum and can be associated with adverse effects
such as nephrotoxicity and anaemia [16, 17]. However,
IRLP has been shown to be an effective technique for
obtaining high drug concentrations in tissue [18–21],
and the high concentration of amphotericin B in the in-
fected tissue enhances the efficacy of the drug against
Pythium insidiosum. Increased concentrations of
amphotericin B impair or inhibit this oomycete’s essen-
tial metabolic processes and result in the death of the
microorganism [5], as demonstrated in this study.
Systemically administered medical treatment of horses
for pythiosis has been reported to be marginally effective
when the lesions were located in the limbs [22]. Local
thrombosis, ischemia, tissue necrosis, and abscess for-
mation, the typical characteristics of pythiosis lesions,
decrease the local blood supply and thus decrease the ef-
fective therapeutic drug concentration that reaches
Pythium insidiosum [23, 24]. The inability to completely
resect a lesion because of its proximity to joints or bones
adds to the challenge of treating horses for cutaneous
pythiosis and favours the persistence of the infection.
According to some previous reports, only horses with
small, superficial lesions of pythiosis can be treated suc-
cessfully [25, 26]. Dória et al. [5], however, were able to
resolve the lesion caused by pythiosis in 92 % of affected
horses, regardless of the size of the lesion, by using a
combination of either complete or partial surgical exci-
sion, thermocautery, and administration of one or two
IRLP of amphotericin B. Complications associated with
IRLP of amphotericin B, such as oedema of the limb,
signs of pain during palpation of the limb, and inflam-
mation at the site of venipuncture, were local and re-
solved. Similarly, the current study demonstrates that
the combination of amphotericin B and DMSO provides
excellent results. All 15 of the horses (100 %) showed
complete resolution of their lesion after a single intra-
venous regional perfusion, without systemic or local
complications, and all lesions were large, some involving
the complete circumference of the limb.
Dória et al. [5] reported that excision of the exuberant
granulation tissue alone is not sufficient to resolve an in-
fection of a limb caused by Pythium insidiosum. In
chronic conditions, there is more fibrosis and scarring,
which further isolate the protistal organism from the
body’s defense mechanisms as well as from systemically
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Fig. 1 Healing of pythiosis lesions treated with amphotericin B and DMSO by IRLP in horses. Progression of healing of pythiosis lesions in the
limb of horses treated with a single administration of amphotericin B in a 10 % DMSO solution by intravenous regional perfusion. Note lesions
before (Day 0; left; a), 4 (middle; b), and 8 (right; c)weeks after the treatment
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administered antifungal drugs [24, 27]. A high concen-
tration of an antifungal drug can be achieved in chronic-
ally infected tissue by intravenous regional perfusion [24,
28], as demonstrated in this study. All of the horses
treated with IRLP of amphotericin B in a 10 % DMSO
solution had complete resolution of their lesion with no
recurrence at the time of follow-up one year later, even
though excision of the infected tissue was incomplete.
We observed, 1 week after treatment, that the granula-
tion tissue was devoid of exudate and that the sinuses and
kunkers were no longer present, indicating that infection
by Pythium insidiosum had resolved completely. Healing
period was related to the size of the lesion. The larger the
lesion, the longer the time the lesion took to heal.
The horses had anaemia before surgery and this has
been observed previously [29–31]. There was also
marked leukocytosis with neutrophilia and eosinophilia
before treatment [2, 16]. Administration of a combin-
ation of amphotericin B and DMSO by IRLP was effect-
ive in treating horses for cutaneous pythiosis of the limb
and evidence of resolution of infection included a
marked decrease in the total leukocyte count by 2 weeks
and return of other haematological values, such as
plasma concentrations of acute phase protein and fi-
brinogen, to normal by 2 weeks after treatment. No
changes were observed in the serum enzyme activities
after the IRLP of amphotericin B and DMSO suggesting
that IRLP with amphotericn B did not cause systemic
complications, such as liver and/or kidney dysfunction,
which have been reported to occur when amphotericin
B is administered systemically [32–35]. Studies have found
that by administering a drug by IRLP, the concentration of
the drug at the site of the disease can be increased many
fold without risk of reaching a toxic concentration of the
drug systemically [19, 24, 36–38]. IRLP allows a wider use
of drugs that are considered hazardous and expensive
when systemically administered to horses [39, 40], such as
amphotericin B [4, 17, 34, 35, 41].
We administered 50 mg amphotericin B in lactated
Ringer’s solution by IRLP, as reported by Dória et al. [5]
but added 6 mL DMSO (10 % of the total volume) to
compose the final solution. The dose and the total vol-
ume of amphotericin B (0.83 mg/mL/60 mL) and DMSO
(6 mL/60 mL) were standardized in this study and were
administered irrespective of the horse’s age and body
weight, the size of the lesion, and the site on the limb at
which the tourniquet was applied. We believe that the
addition of DMSO to the perfusate prevented vascular
inflammation typically induced by IRLP of amphotericin
B and reported by Dória et al. [5]. DMSO is a potent
anti-inflammatory agent that acts, through the activity of
superoxide dismutase, to suppress production of prosta-
glandins, to limit production of free radicals, and to
scavenge free radicals [9, 42]. DMSO has multiple prop-
erties that can be beneficial when used as adjunctive
treatment for sepsis. DMSO reduces platelet aggregation
and thus decreases the incidence of thrombus formation
in small vessels. This activity helps to normalize tissue
perfusion in the face of the vascular insults that often ac-
company septic conditions of the equine extremities.
Table 1 Haematology and biochemistry in horses with pythiosis treated by IRLP with amphotericin B and DMSO. Mean values of
haematology and selected blood biochemistry tests before (week 0) and after (1 to 9 weeks) intravenous regional perfusion with























0 6.17 26ab 21a 15.38a 949.83a 5.2 74d 192d 17.30d 306.53d 112.27ad 13.24d
1 5.54 24a 14.32ab 10.15ab 827.20ab 4.6 75d 163d 20.78d 213.33d 74.26bd 13.02d
2 6.65d 28ab 11.54bcd 7.41bcd 577.43abd 4d 77d 167d 18.49d 254.12d 79.56bd 14.40d
3 6.74d 29ab 10.77bcd 6.24bcd 571.83abd 3.7d 75d 181d 15.38d 222.53d 79.56bd 13.97d
4 7.25d 31b 10.48bcd 5.98bcd 438.33abd 2d 75d 194d 13.77d 273.51d 78.68bd 16.25d
5 7.45d 31b 9.28bcd 5.32bcd 346.67abd 2.7d 72d 214d 15.94d 268.19d 80.44bd 17.04d
6 7.34d 32bd 8.67bcd 4.55cd 334.17abd 3d 72d 184d 17.85d 210.73d 80.44bd 18.58d
7 7.38d 31b 8.38cd 5.04bcd 287.17bd 2d 72d 196d 14.17d 211.73d 94.59abd 17.83d
8 7.80d 33bd 9.13bcd 5.06bcd 315abd 2d 72d 195d 14.40d 200.18d 84.86abd 13.54d
9 7.66d 32abd 9.13bcd 5.41bcd 189abd 2d 69d 221d 13.80d 277.28d 83.98abd 13.05d
Reference
range22
6.4–10.0 32–47 5.2–13.9 2.26–8.58 0–600 1–4 57–79 152–294 9–25 143–395 88.4–167.96 9.21–19.96
RBC red blood cell count, PCV packed cell volume, TLC total leukocytic count, SN segmented neutrophils, E eosinophils, F fibrinogen, TP total protein, AST aspartate
aminotransferase, GGT gamma-glutamyltransferase, ALP alkaline phosphatase, CR creatinine, U urea nitrogen
*Significant at probability ≤ 0.05
a; b; c - means with different letters are significantly different (Tukey’s test; P ≤ 0.05); d Mean value inside reference range
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The inhibitory effects of DMSO on the growth of a var-
iety of bacteria, viruses, and fungi have been docu-
mented by a number of studies [6, 7]. The bacteriostatic
and bactericidal effects of DMSO may be the result of
the drug’s ability to penetrate biological membranes [8,
9]. A drug that possesses these qualities is likely to at-
tenuate some of the deleterious effects of vascular injury
and free radical production inherent in septic conditions
of the limb by affording a potent anti-inflammatory ef-
fect and aiding in tissue perfusion [10]. It is noteworthy
that DMSO is not a licensed drug therefore it is not
allowed for treatment in many countries.
We assumed that by using an appropriate rate of infu-
sion, the increased intravascular pressure would favour
the diffusion of amphotericin B through the tissues and
enhance the drug’s concentration in the target tissues
[40, 43, 44] and that the combination with DMSO would
increase the drug’s diffusion through the affected tissues,
providing better resolution of infection than when
amphotericin B is administered alone. In contrast with
the study by Dória et al. [5], here only one IRLP with
amphotericin B and DMSO was necessary to resolve a
large wound on a limb caused by chronic pythiosis. Ad-
ministering DMSO and a low dosage of amphotericin B
by IRLP caused no systemic or local complications and
is likely to be safer and more economical than adminis-
tering amphotericin B systemically.
Conclusion
This small case series demonstrates that in association
with surgical excision of the exuberant granulation tissue
caused by Pythium insidiosum infection, a single IRLP
administration of 50 mg of amphotericin B and DMSO
(10 % of the total solution) was an effective technique
for treating horses for pythiosis of a limb that produced
no noticeable local or systemic complications.
Endnotes
1Anfotericin B®, Cristália, São Paulo, Brazil.
2Dimesol®, Marcolab, São Paulo, Brazil.
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